126 related articles for article (PubMed ID: 1833226)
21. Migration-stimulating factor displays HEXXH-dependent catalytic activity important for promoting tumor cell migration.
Houard X; Germain S; Gervais M; Michaud A; van den Brûle F; Foidart JM; Noël A; Monnot C; Corvol P
Int J Cancer; 2005 Sep; 116(3):378-84. PubMed ID: 15800942
[TBL] [Abstract][Full Text] [Related]
22. Differences between adult and foetal fibroblasts in the regulation of hyaluronate synthesis: correlation with migratory activity.
Chen WY; Grant ME; Schor AM; Schor SL
J Cell Sci; 1989 Nov; 94 ( Pt 3)():577-84. PubMed ID: 2632585
[TBL] [Abstract][Full Text] [Related]
23. Angiogenesis and tumour progression: migration-stimulating factor as a novel target for clinical intervention.
Schor AM; Schor SL
Eye (Lond); 2010 Mar; 24(3):450-8. PubMed ID: 20019766
[TBL] [Abstract][Full Text] [Related]
24. Differential motogenic and biosynthetic response of fetal and adult skin fibroblasts to TGF-beta isoforms.
Ellis IR; Schor SL
Cytokine; 1998 Apr; 10(4):281-9. PubMed ID: 9617573
[TBL] [Abstract][Full Text] [Related]
25. Migration Stimulating Factor (MSF) promotes fibroblast migration by inhibiting AKT.
Ellis IR; Jones SJ; Lindsay Y; Ohe G; Schor AM; Schor SL; Leslie NR
Cell Signal; 2010 Nov; 22(11):1655-9. PubMed ID: 20600851
[TBL] [Abstract][Full Text] [Related]
26. Occurrence of a fetal fibroblast phenotype in familial breast cancer.
Schor SL; Haggie JA; Durning P; Howell A; Smith L; Sellwood RA; Crowther D
Int J Cancer; 1986 Jun; 37(6):831-6. PubMed ID: 3710614
[TBL] [Abstract][Full Text] [Related]
27. Fibroblasts from relatives of patients with hereditary breast cancer show fetal-like behaviour in vitro.
Haggie JA; Sellwood RA; Howell A; Birch JM; Schor SL
Lancet; 1987 Jun; 1(8548):1455-7. PubMed ID: 2885452
[TBL] [Abstract][Full Text] [Related]
28. Motogenic and biosynthetic response of adult skin fibroblasts to TGF-beta isoforms (-1, -2 and -3) determined by 'tissue response unit': role of cell density and substratum.
Ellis IR; Banyard J; Schor SL
Cell Biol Int; 1999; 23(9):593-602. PubMed ID: 10728570
[TBL] [Abstract][Full Text] [Related]
29. The differential proliferative response of fetal and adult human skin fibroblasts to TGF-β is retained when cultured in the presence of fibronectin or collagen.
Armatas AA; Pratsinis H; Mavrogonatou E; Angelopoulou MT; Kouroumalis A; Karamanos NK; Kletsas D
Biochim Biophys Acta; 2014 Aug; 1840(8):2635-42. PubMed ID: 24735795
[TBL] [Abstract][Full Text] [Related]
30. Migration stimulating activity in serum of breast cancer patients.
Picardo M; Schor SL; Grey AM; Howell A; Laidlaw I; Redford J; Schor AM
Lancet; 1991 Jan; 337(8734):130-3. PubMed ID: 1670786
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic heterogeneity in breast fibroblasts: functional anomaly in fibroblasts from histologically normal tissue adjacent to carcinoma.
Schor AM; Rushton G; Ferguson JE; Howell A; Redford J; Schor SL
Int J Cancer; 1994 Oct; 59(1):25-32. PubMed ID: 7927899
[TBL] [Abstract][Full Text] [Related]
32. Human peri-tumoral and lung fibroblasts produce paracrine motility factors for recently established human sarcoma cell strains.
Hu M; Pollock RE; Nakamura T; Nicolson GL
Int J Cancer; 1995 Sep; 62(5):585-92. PubMed ID: 7665230
[TBL] [Abstract][Full Text] [Related]
33. Fetal-like fibroblasts: their production of migration-stimulating factor and role in tumor progression.
Schor SL; Grey AM; Ellis I; Schor AM; Howell A; Sloan P; Murphy R
Cancer Treat Res; 1994; 71():277-98. PubMed ID: 7946952
[No Abstract] [Full Text] [Related]
34. The stimulatory effects of alpha1-adrenergic receptors on TGF-beta1, IGF-1 and hyaluronan production in human skin fibroblasts.
Liao MH; Liu SS; Peng IC; Tsai FJ; Huang HH
Cell Tissue Res; 2014 Sep; 357(3):681-93. PubMed ID: 24844469
[TBL] [Abstract][Full Text] [Related]
35. Fetal dermal fibroblasts retain a hyperactive migratory and contractile phenotype under 2-and 3-dimensional constraints compared to normal adult fibroblasts.
Sandulache VC; Parekh A; Dohar JE; Hebda PA
Tissue Eng; 2007 Nov; 13(11):2791-801. PubMed ID: 17764403
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic and genetic alterations in mammary stroma: implications for tumour progression.
Schor SL; Schor AM
Breast Cancer Res; 2001; 3(6):373-9. PubMed ID: 11737888
[TBL] [Abstract][Full Text] [Related]
37. Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility.
Solinas G; Schiarea S; Liguori M; Fabbri M; Pesce S; Zammataro L; Pasqualini F; Nebuloni M; Chiabrando C; Mantovani A; Allavena P
J Immunol; 2010 Jul; 185(1):642-52. PubMed ID: 20530259
[TBL] [Abstract][Full Text] [Related]
38. Migration-stimulating factor (MSF) is over-expressed in non-small cell lung cancer and promotes cell migration and invasion in A549 cells over-expressing MSF.
Deng X; Ma Q; Zhang B; Jiang H; Zhang Z; Wang Y
Exp Cell Res; 2013 Oct; 319(17):2545-53. PubMed ID: 23791940
[TBL] [Abstract][Full Text] [Related]
39. The role of the fetal fibroblast and transforming growth factor-beta in a model of human fetal wound repair.
Lin RY; Adzick NS
Semin Pediatr Surg; 1996 Aug; 5(3):165-74. PubMed ID: 8858763
[TBL] [Abstract][Full Text] [Related]
40. The role of interleukin-10 and hyaluronan in murine fetal fibroblast function in vitro: implications for recapitulating fetal regenerative wound healing.
Balaji S; King A; Marsh E; LeSaint M; Bhattacharya SS; Han N; Dhamija Y; Ranjan R; Le LD; Bollyky PL; Crombleholme TM; Keswani SG
PLoS One; 2015; 10(5):e0124302. PubMed ID: 25951109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
